These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1034 related articles for article (PubMed ID: 17499349)
1. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349 [TBL] [Abstract][Full Text] [Related]
2. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. Pierce RC; Kalivas PW J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. Sorg BA; Li N; Wu WR J Pharmacol Exp Ther; 2001 May; 297(2):501-8. PubMed ID: 11303036 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257 [TBL] [Abstract][Full Text] [Related]
6. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. Wang JQ; McGinty JF J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408 [TBL] [Abstract][Full Text] [Related]
7. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists. Cauli O; Morelli M Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482 [TBL] [Abstract][Full Text] [Related]
8. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
9. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens. Rouillon C; Abraini JH; David HN Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350 [TBL] [Abstract][Full Text] [Related]
10. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation. Rowlett JK; Mattingly BA; Bardo MT Synapse; 1993 Jun; 14(2):160-8. PubMed ID: 8332946 [TBL] [Abstract][Full Text] [Related]
11. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Berridge KC; Aldridge JW Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041 [TBL] [Abstract][Full Text] [Related]
12. Activation of dopamine D1 receptors in the medial prefrontal cortex produces bidirectional effects on cocaine-induced locomotor activity in rats: effects of repeated stress. Sorg BA; Li N; Wu W; Bailie TM Neuroscience; 2004; 127(1):187-96. PubMed ID: 15219681 [TBL] [Abstract][Full Text] [Related]
13. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats. Shuto T; Seeman P; Kuroiwa M; Nishi A Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579 [TBL] [Abstract][Full Text] [Related]
14. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates. Byrnes EM; Bruno JP Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729 [TBL] [Abstract][Full Text] [Related]
15. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. Pierce RC; Born B; Adams M; Kalivas PW J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine. Chocyk A; Czyrak A; Wedzony K J Physiol Pharmacol; 2008 Sep; 59(3):425-40. PubMed ID: 18953088 [TBL] [Abstract][Full Text] [Related]
17. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Schmidt HD; Pierce RC Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308 [TBL] [Abstract][Full Text] [Related]
19. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. Hess EJ; Albers LJ; Le H; Creese I J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223 [TBL] [Abstract][Full Text] [Related]
20. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS; Joyce JN Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]